CAPRIE trial (multiple letters) [10]

Lancet

Volumn 349, Issue 9048, 1997, Pages 354-356

  Violi, F ^a   Toplak, H ^a   Bahadori, B ^a   Wascher, T C ^a   Green, D ^a   Davie, A P ^a   Love, M P ^a   Barer, D ^a   Gent, M ^a   Hampton, J R ^a   Roberts, R S ^a   Verstraete, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; HEART INFARCTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; SECONDARY PREVENTION; APLASTIC ANEMIA; BRAIN INFARCTION; CASE REPORT; CHEMICALLY INDUCED DISORDER; CONTROLLED CLINICAL TRIAL; MALE; MIDDLE AGED; NOTE; RANDOMIZED CONTROLLED TRIAL; BRAIN ISCHEMIA; METHODOLOGY; PERIPHERAL VASCULAR DISEASE; TREATMENT OUTCOME; COMPARATIVE STUDY;

ANEMIA, APLASTIC; CEREBRAL INFARCTION; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; TICLOPIDINE; ASPIRIN; BRAIN ISCHEMIA; MYOCARDIAL INFARCTION; PERIPHERAL VASCULAR DISEASES; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 0031065291     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)26005-8     Document Type: Letter

References (17)